肝素诱导的血小板缺血的管理:当代审查
Jun Yen Ng1, Melanie D'Souza1, Felanita Hutani1
1Department of Hematology, Canberra Hospital, Canberra 2605, Australia.
Journal of clinical medicine
|August 29, 2024
概括
氨酸诱导的血栓塞缩症 (HIT) 是对氨酸的严重免疫反应,导致血栓形成. 早期识别和非肝素抗凝剂,包括较新的口服选择,改善了患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸诱导的血小板缺血 (HIT) 是氨酸治疗的严重免疫中介并发症.
- 第二类HIT涉及对血小板因子4 (PF4) - 氨酸复合体的抗体,导致血栓形成和血栓细胞减小.
- 高发病率和死亡率需要及时诊断和管理.
研究的目的:
- 审查II型HIT的管理,重点关注最近的进展.
- 将HIT阶段纳入基于临床和实验室发现的管理策略.
- 评估直接作用的口服抗凝剂 (DOAC) 在急性HIT管理中的作用.
主要方法:
- 关于HIT管理的当前文献的综述.
- 分析HIT阶段 (疑似,急性,亚急性,远程) 以量身定制的治疗.
- 评估DOACs作为一种替代HIT的亲肠道抗凝剂.
主要成果:
- 管理策略正在不断发展,以纳入HIT疾病阶段.
- 直接作用的口服抗凝剂 (DOACs) 对急性HIT有希望,提供更容易的管理和成本效益.
- DOACs可以通过消除康复后需要过渡到口服抗凝药来简化治疗.
结论:
- 有效的HIT管理需要早期识别和及时干预.
- 阶段性管理和明智地使用DOACs代表了治疗HIT的重大进展.
- 需要进一步的研究来解决在HIT管理中的现有知识差距.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
654
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
654
Introduction to Hemostasis
6.7K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.7K
Esophageal Varices-II: Clinical Features and Management
57
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
57
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
499
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
499
Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K
Disorders of Hemostasis
754
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
754


